TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE
发明人:
Surjit MILAN,Saumya ANANG
申请号：
US16627516
公开号：
US20200115417A1
申请日:
2018.07.23
申请国别(地区):
US
年份:
2020
代理人:
摘要：
An objective of the present invention is to provide a means for inhibiting progression of HEV infection in a host by use of a cyclic peptide including the amino acid sequence of SEQ ID No: 1 which inhibits interaction between HEV ORF3 domain and host TSG101 which is crucial for HEV proliferation in a host or an expression vector coding for the cyclic peptide or a pharmaceutical composition comprising the cyclic peptide with pharmaceutically acceptable carriers.
